Literature DB >> 11724834

Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses".

G Belliot1, J S Noel, J F Li, Y Seto, C D Humphrey, T Ando, R I Glass, S S Monroe.   

Abstract

"Norwalk-like viruses" (NLVs), members of a newly defined genus of the family Caliciviridae, are the most common agents of outbreaks of gastroenteritis in the United States. Two features of NLVs have hindered the development of simple methods for detection and determination of serotype: their genetic diversity and their inability to grow in cell culture. To assess the immune responses of patients involved in outbreaks of gastroenteritis resulting from infection with NLVs, we previously used recombinant-expressed capsid antigens representing four different genetic clusters, but this panel proved insufficient for detection of an immune response in many patients. To extend and further refine this panel, we expressed in baculovirus the capsid genes of three additional genetically distinct viruses, Burwash Landing virus (BLV), White River virus (WRV), and Florida virus. All three expressed proteins assembled into virus-like particles (VLPs) that contained a full-length 64-kDa protein, but both the BLV and WRV VLPs also contained a 58-kDa protein that resulted from deletion of 39 amino acids at the amino terminus. The purified VLPs were used to measure the immune responses in 403 patients involved in 37 outbreaks of acute gastroenteritis. A majority of patients demonstrated a fourfold rise in the titer of immunoglobulin G to the antigen homologous to the outbreak strain, but most seroconverted in response to other genetically distinct antigens as well, suggesting no clear pattern of type-specific immune response. Further study of the antigenicity of the NLVs by use of VLPs should allow us to design new detection systems with either broader reactivity or better specificity and to define the optimum panel of antigens required for routine screening of patient sera.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724834      PMCID: PMC88538          DOI: 10.1128/JCM.39.12.4288-4295.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

Review 1.  Genetic classification of "Norwalk-like viruses..

Authors:  T Ando; J S Noel; R L Fankhauser
Journal:  J Infect Dis       Date:  2000-05       Impact factor: 5.226

2.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Antigenic relatedness among the Norwalk-like agents by serum antibody rises.

Authors:  H P Madore; J J Treanor; R Buja; R Dolin
Journal:  J Med Virol       Date:  1990-10       Impact factor: 2.327

4.  Sequence and genomic organization of Norwalk virus.

Authors:  X Jiang; M Wang; K Wang; M K Estes
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

5.  Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus.

Authors:  J J Gray; C Cunliffe; J Ball; D Y Graham; U Desselberger; M K Estes
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

6.  Antigenic diversity of Norwalk-like viruses: expression of the capsid protein of a genogroup I virus, distantly related to Norwalk virus.

Authors:  M Myrmel; E Rimstad
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

7.  Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations.

Authors:  K Y Green; J F Lew; X Jiang; A Z Kapikian; M K Estes
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  Molecular characterization of Hawaii virus and other Norwalk-like viruses: evidence for genetic polymorphism among human caliciviruses.

Authors:  J F Lew; A Z Kapikian; J Valdesuso; K Y Green
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

9.  Human enteric Caliciviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus.

Authors:  K E Dingle; P R Lambden; E O Caul; I N Clarke
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

10.  Enzyme immunoassay using baculovirus-expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK.

Authors:  S P Parker; W D Cubitt; X Jiang
Journal:  J Med Virol       Date:  1995-07       Impact factor: 2.327

View more
  32 in total

1.  Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France.

Authors:  Béatrice Nicollier-Jamot; Valérie Pico; Pierre Pothier; Evelyne Kohli
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples.

Authors:  Jonathan A Burton-MacLeod; Erin M Kane; Rachel S Beard; Leslie A Hadley; Roger I Glass; Tamie Ando
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly.

Authors:  Kim Y Green; Gaël Belliot; Jean Lin Taylor; José Valdesuso; Judy F Lew; Albert Z Kapikian; Feng-Ying C Lin
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

4.  Bioluminescent enzyme immunoassay for the detection of norovirus capsid antigen.

Authors:  Nozomi Sakamaki; Yoshiyuki Ohiro; Mitsuki Ito; Mitsuru Makinodan; Tsubasa Ohta; Wataru Suzuki; Susumu Takayasu; Harufumi Tsuge
Journal:  Clin Vaccine Immunol       Date:  2012-10-17

5.  Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.

Authors:  Yuqi Huo; Xuhui Chen; Lijun Zheng; Jinling Huo; Shanfeng Zhang; Mingchen Wang; Yumei Wang
Journal:  Virus Genes       Date:  2016-05-27       Impact factor: 2.332

6.  Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.

Authors:  A de Rougemont; N Ruvoen-Clouet; B Simon; M Estienney; C Elie-Caille; S Aho; P Pothier; J Le Pendu; W Boireau; G Belliot
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

7.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein.

Authors:  Andrea Bertolotti-Ciarlet; Sue E Crawford; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

Authors:  L Huhti; V Blazevic; K Nurminen; T Koho; V P Hytönen; T Vesikari
Journal:  Arch Virol       Date:  2010-08-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.